Arvind Gharbharan

Convalescent Plasma for COVID-19. A randomized clinical trial

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · 2020 · 237 citations · Full text

Vaccination, Immunohematology, Structured Abstract +14

A comparative study of software programmes for cross‐sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients

Jeroen L.A. van Vugt, Stef Levolger, Arvind Gharbharan et al. · Journal of Cachexia Sarcopenia and Muscle · 2016 · 210 citations · Full text

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · Nature Communications · 2021 · 158 citations · Full text

Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

Sammy Huygens, Bas B. Oude Munnink, Arvind Gharbharan et al. · Clinical Infectious Diseases · 2022 · 50 citations · Full text

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

Matthijs P. Raadsen, Arvind Gharbharan, Carlijn Jordans et al. · Journal of Clinical Immunology · 2021 · 47 citations · Full text